These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 19769866)

  • 21. [The treatment of the exsudative age-related macular degeneration with choroidal neovascular membrane, its possibilities and economical indexes].
    Karel I
    Cesk Slov Oftalmol; 2007 Sep; 63(5):311-9. PubMed ID: 17915581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pigment epithelial tears associated with anti-VEGF therapy: incidence, long-term visual outcome, and relationship with pigment epithelial detachment in age-related macular degeneration.
    Doguizi S; Ozdek S
    Retina; 2014 Jun; 34(6):1156-62. PubMed ID: 24296398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The importance of informed consent in patients with wet age-related macular degeneration considering intravitreal anti-vascular endothelial growth factor treatments.
    McLaughlin S; Lockington D; Mansfield D
    Scott Med J; 2012 Feb; 57(1):48-9. PubMed ID: 22408217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retinal pigment epithelial tears in the era of intravitreal pharmacotherapy: risk factors, pathogenesis, prognosis and treatment (an American Ophthalmological Society thesis).
    Sarraf D; Joseph A; Rahimy E
    Trans Am Ophthalmol Soc; 2014 Jul; 112():142-59. PubMed ID: 25646033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Triple therapy for the treatment of choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration].
    Hajouli N; Hiesch A; Quintyn JC
    J Fr Ophtalmol; 2010 Sep; 33(7):487-92. PubMed ID: 20452090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between systemic anticoagulation and rate of intraocular hemorrhage following intravitreal anti-VEGF therapy for age-related macular degeneration.
    Olson JM; Scott IU; Kerchner DL; Kunselman AR
    Ophthalmic Surg Lasers Imaging Retina; 2013; 44(5):455-9. PubMed ID: 24044707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Relationship between intravitreal anti-VEGF therapy and subretinal hemorrhage in patients with exudative age-related macular degeneration].
    Kauffmann Y; Isaico R; Lefebvre A; Bron AM; Creuzot-Garcher C
    J Fr Ophtalmol; 2014 Mar; 37(3):195-201. PubMed ID: 24534623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-VEGF agents for age-related macular degeneration.
    Ozkiris A
    Expert Opin Ther Pat; 2010 Jan; 20(1):103-18. PubMed ID: 20021287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subretinal hemorrhages associated with age-related macular degeneration in patients receiving anticoagulation or antiplatelet therapy.
    Kuhli-Hattenbach C; Fischer IB; Schalnus R; Hattenbach LO
    Am J Ophthalmol; 2010 Feb; 149(2):316-321.e1. PubMed ID: 19939348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recurrent submacular hemorrhage in patients with neovascular age-related macular degeneration.
    Hwang JU; Yang SJ; Yoon YH; Lee JY; Kim JG
    Retina; 2012 Apr; 32(4):652-7. PubMed ID: 22366903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgical treatment of age-related macular degeneration.
    Skaf AR; Mahmoud T
    Semin Ophthalmol; 2011 May; 26(3):181-91. PubMed ID: 21609231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomised, double-masked phase III/IV study of the efficacy and safety of Avastin(R) (Bevacizumab) intravitreal injections compared to standard therapy in subjects with choroidal neovascularisation secondary to age-related macular degeneration: clinical trial design.
    Patel PJ; Bunce C; Tufail A;
    Trials; 2008 Oct; 9():56. PubMed ID: 18854025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An update on the pharmacotherapy of neovascular age-related macular degeneration.
    Freund KB; Mrejen S; Gallego-Pinazo R
    Expert Opin Pharmacother; 2013 Jun; 14(8):1017-28. PubMed ID: 23560774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endophthalmitis following intravitreal anti-vascular endothelial growth factor injections for neovascular age-related macular degeneration.
    Moshfeghi AA
    Semin Ophthalmol; 2011 May; 26(3):139-48. PubMed ID: 21609227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retinal pigment epithelial tear following intravitreal pegaptanib sodium.
    Dhalla MS; Blinder KJ; Tewari A; Hariprasad SM; Apte RS
    Am J Ophthalmol; 2006 Apr; 141(4):752-4. PubMed ID: 16564819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of gene therapy for treatment of age-related macular degeneration.
    Askou AL
    Acta Ophthalmol; 2014 Jul; 92 Thesis3():1-38. PubMed ID: 24953666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aflibercept for age-related macular degeneration: a game-changer or quiet addition?
    Browning DJ; Kaiser PK; Rosenfeld PJ; Stewart MW
    Am J Ophthalmol; 2012 Aug; 154(2):222-6. PubMed ID: 22813448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Macular translocation with 360 degrees retinotomy for management of retinal pigment epithelial tear: long-term results.
    Polito A; Cereda M; Romanelli F; Pertile G
    Br J Ophthalmol; 2011 Jan; 95(1):74-8. PubMed ID: 20576765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of intravitreal anti-vascular endothelial growth factor injection and its complications in Chiang Mai University Hospital.
    Kunavisarut P; Saenpen N; Ittipunkul N; Patikulsila D; Choovuthayakorn J; Watanachai N; Pathanapitoon K
    J Med Assoc Thai; 2013 Nov; 96(11):1483-90. PubMed ID: 24428099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Submacular hemorrhage in neovascular age-related macular degeneration: A synthesis of the literature.
    Stanescu-Segall D; Balta F; Jackson TL
    Surv Ophthalmol; 2016; 61(1):18-32. PubMed ID: 26212151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.